Literature DB >> 22414604

Perfluorooctanoic acid effects on ovaries mediate its inhibition of peripubertal mammary gland development in Balb/c and C57Bl/6 mice.

Yong Zhao1, Ying S Tan2, Mark J Strynar3, Gloria Perez4, Sandra Z Haslam5, Chengfeng Yang6.   

Abstract

Exposure to perfluorooctanoic acid (PFOA), a synthetic perfluorinated compound and an agonist of peroxisome proliferator-activated receptor α (PPARα), causes stunted mouse mammary gland development in various developmental stages. However, the underlying mechanisms remain poorly understood. We found that peripubertal PFOA exposure significantly inhibited mammary gland growth in both Balb/c and C57Bl/6 wild type mice, but not in C57Bl/6 PPARα knockout mice, and Balb/c mice were more sensitive to PFOA inhibition. PFOA caused (1) delayed or absence of vaginal opening and lack of estrous cycling during the experimental period; (2) decreases in ovarian steroid hormonal synthetic enzyme levels; and (3) reduced expression of estrogen- or progesterone-induced mammary growth factors. Supplementation with exogenous estrogen and/or progesterone reversed the PFOA inhibitory effect on mammary gland. These results indicate that PFOA effects on ovaries mediate its inhibition of mammary gland development in Balb/c and C57Bl/6 mice and that PPARα expression is a contributing factor.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22414604      PMCID: PMC3362693          DOI: 10.1016/j.reprotox.2012.02.004

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  46 in total

Review 1.  Roles of hepatocyte growth factor/scatter factor and transforming growth factor-beta1 in mammary gland ductal morphogenesis.

Authors:  J V Soriano; M S Pepper; L Orci; R Montesano
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

Review 2.  Progesterone action and responses in the alphaERKO mouse.

Authors:  S C Hewitt; K S Korach
Journal:  Steroids       Date:  2000 Oct-Nov       Impact factor: 2.668

3.  Prenatal perfluorooctanoic acid exposure in CD-1 mice: low-dose developmental effects and internal dosimetry.

Authors:  Madisa B Macon; LaTonya R Villanueva; Katoria Tatum-Gibbs; Robert D Zehr; Mark J Strynar; Jason P Stanko; Sally S White; Laurence Helfant; Suzanne E Fenton
Journal:  Toxicol Sci       Date:  2011-04-11       Impact factor: 4.849

4.  Interactions among peroxisome proliferator activated receptor-gamma, insulin signaling pathways, and steroidogenic acute regulatory protein in human ovarian cells.

Authors:  Donna Seto-Young; Dimiter Avtanski; Marina Strizhevsky; Grishma Parikh; Parini Patel; Julia Kaplun; Kevin Holcomb; Zev Rosenwaks; Leonid Poretsky
Journal:  J Clin Endocrinol Metab       Date:  2007-03-20       Impact factor: 5.958

5.  Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes.

Authors:  J A Bjork; J L Butenhoff; K B Wallace
Journal:  Toxicology       Date:  2011-06-23       Impact factor: 4.221

6.  Sex hormone-regulated renal transport of perfluorooctanoic acid.

Authors:  Naomi Kudo; Masanori Katakura; Yasunori Sato; Yoichi Kawashima
Journal:  Chem Biol Interact       Date:  2002-03-20       Impact factor: 5.192

Review 7.  Hormone/growth factor interactions mediating epithelial/stromal communication in mammary gland development and carcinogenesis.

Authors:  Walter Imagawa; Vadim K Pedchenko; Jennifer Helber; Hongzheng Zhang
Journal:  J Steroid Biochem Mol Biol       Date:  2002-02       Impact factor: 4.292

Review 8.  Endocrine disrupting properties of perfluorooctanoic acid.

Authors:  Sally S White; Suzanne E Fenton; Erin P Hines
Journal:  J Steroid Biochem Mol Biol       Date:  2011-03-21       Impact factor: 4.292

Review 9.  Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals.

Authors:  Naomi Kudo; Yoichi Kawashima
Journal:  J Toxicol Sci       Date:  2003-05       Impact factor: 2.196

Review 10.  Identifying critical windows of exposure for children's health.

Authors:  S G Selevan; C A Kimmel; P Mendola
Journal:  Environ Health Perspect       Date:  2000-06       Impact factor: 9.031

View more
  23 in total

1.  Perfluorooctanoic Acid (PFOA)-induced Liver Lesions in Two Strains of Mice Following Developmental Exposures: PPARα Is Not Required.

Authors:  Adam J Filgo; Erin M Quist; Mark J Hoenerhoff; Amy E Brix; Grace E Kissling; Suzanne E Fenton
Journal:  Toxicol Pathol       Date:  2014-11-14       Impact factor: 1.902

2.  Associations of Perfluoroalkyl Substances with Incident Natural Menopause: The Study of Women's Health Across the Nation.

Authors:  Ning Ding; Siobán D Harlow; John F Randolph; Antonia M Calafat; Bhramar Mukherjee; Stuart Batterman; Ellen B Gold; Sung Kyun Park
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

Review 3.  Endocrine disruptors and the breast: early life effects and later life disease.

Authors:  Madisa B Macon; Suzanne E Fenton
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-02-17       Impact factor: 2.673

4.  Perfluoroalkyl substances and ovarian hormone concentrations in naturally cycling women.

Authors:  Emily S Barrett; Chongshu Chen; Sally W Thurston; Line Småstuen Haug; Azemira Sabaredzovic; Frøydis Nyborg Fjeldheim; Hanne Frydenberg; Susan F Lipson; Peter T Ellison; Inger Thune
Journal:  Fertil Steril       Date:  2015-03-04       Impact factor: 7.329

5.  Maternal serum perfluoroalkyl substances during pregnancy and duration of breastfeeding.

Authors:  Megan E Romano; Yingying Xu; Antonia M Calafat; Kimberly Yolton; Aimin Chen; Glenys M Webster; Melissa N Eliot; Cynthia R Howard; Bruce P Lanphear; Joseph M Braun
Journal:  Environ Res       Date:  2016-05-11       Impact factor: 6.498

6.  Perfluoroalkyl substances and changes in bone mineral density: A prospective analysis in the POUNDS-LOST study.

Authors:  Yang Hu; Gang Liu; Jennifer Rood; Liming Liang; George A Bray; Lilian de Jonge; Brent Coull; Jeremy D Furtado; Lu Qi; Philippe Grandjean; Qi Sun
Journal:  Environ Res       Date:  2019-09-27       Impact factor: 6.498

7.  Perfluorooctanoate and changes in anthropometric parameters with age in young girls in the Greater Cincinnati and San Francisco Bay Area.

Authors:  S M Pinney; G C Windham; C Xie; R L Herrick; A M Calafat; K McWhorter; C S Fassler; R A Hiatt; L H Kushi; F M Biro
Journal:  Int J Hyg Environ Health       Date:  2019-07-09       Impact factor: 5.840

8.  The mammary gland is a sensitive pubertal target in CD-1 and C57Bl/6 mice following perinatal perfluorooctanoic acid (PFOA) exposure.

Authors:  Deirdre K Tucker; Madisa B Macon; Mark J Strynar; Sonia Dagnino; Erik Andersen; Suzanne E Fenton
Journal:  Reprod Toxicol       Date:  2014-12-12       Impact factor: 3.143

Review 9.  Animal models of endocrine disruption.

Authors:  Heather B Patisaul; Suzanne E Fenton; David Aylor
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2018-04-06       Impact factor: 4.690

Review 10.  EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.

Authors:  A C Gore; V A Chappell; S E Fenton; J A Flaws; A Nadal; G S Prins; J Toppari; R T Zoeller
Journal:  Endocr Rev       Date:  2015-11-06       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.